CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-10-08 | Novak Rodger President | Sale | −22,238 | $100.00 | $2.2M | 648,007 |
| 2020-10-08 | Novak Rodger President | Option exercise · Stock Option (Right to Buy) | −22,238 | 193,077 | ||
| 2020-10-05 | TOMSICEK MICHAEL JOHN Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +11,666 | 11,666 | ||
| 2020-10-05 | Kulkarni Samarth Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +47,333 | 47,333 | ||
| 2020-10-05 | Klein Lawrence Otto CBO & COO | Grant or award · Stock Option (Right to Buy) | +16,666 | 16,666 | ||
| 2020-10-05 | KASINGER JAMES R. General Counsel and Secretary | Grant or award · Stock Option (Right to Buy) | +11,666 | 11,666 | ||
| 2020-10-05 | Ho Tony W Executive VP, Head of R&D | Grant or award · Stock Option (Right to Buy) | +16,666 | 16,666 | ||
| 2020-09-22 | Bolzon Bradley J PhD Director | Other disposition | −328,324 | 1,746,493 | ||
| 2020-09-22 | Bolzon Bradley J PhD Director | Other acquisition | +84,544 | 84,544 | ||
| 2020-09-22 | Bolzon Bradley J PhD Director | Other disposition | −84,544 | 0 | ||
| 2020-09-22 | Bolzon Bradley J PhD Director | Other disposition | −1,948 | 10,355 | ||
| 2020-09-22 | Bolzon Bradley J PhD Director | Other acquisition | +14,780 | 22,171 | ||
| 2020-09-18 | Bolzon Bradley J PhD Director | Sale | −3,035 | $86.87 | $264K | 518,190 |
| 2020-09-16 | Bolzon Bradley J PhD Director | Sale | −8,965 | $86.98 | $780K | 521,225 |
| 2020-09-14 | Bolzon Bradley J PhD Director | Sale | −1,155 | $84.89 | $98K | 530,190 |
| 2020-09-10 | Bolzon Bradley J PhD Director | Sale | −14,161 | $85.03 | $1.2M | 540,029 |
| 2020-09-10 | Bolzon Bradley J PhD Director | Sale | −8,684 | $85.90 | $746K | 531,345 |
| 2020-09-09 | Bolzon Bradley J PhD Director | Other disposition | −164,162 | 2,074,817 | ||
| 2020-09-09 | Bolzon Bradley J PhD Director | Other disposition | −974 | 12,303 | ||
| 2020-09-09 | Bolzon Bradley J PhD Director | Other acquisition | +42,272 | 42,272 |
Page 39 of 46 · 910 trades